Diabetes Care 33 , 22712273 (2010)
Positive effects observed in studies include: Reduced liver fat accumulation Lower ALT and AST levels in patients with fatty liver Improved insulin sensitivity, which reduces liver workload Decreased inflammation markers Research published in The Lancet found that semaglutide significantly reduced liver fat and improved fibrosis markers in patients with metabolic dysfunction-associated steatohepatitis (MASH)
There is high certainty that the net benefit is moderate or there is moderate certainty that the net benefit is moderate to substantial
In weeks 4-6 , users may notice improved skin health , as well as the effects of reduced oxidative stress
Since GIPs may also enhance glucagon secretion, it has little pharmacological significance and thus considered not useful as a pharmacological agent for Diabetes treatment
Narration: But then, you know, met my wife, had some kids